Journal
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume 22, Issue 2, Pages 217-240Publisher
SPRINGER
DOI: 10.1007/s11154-021-09635-3
Keywords
Type 1 diabetes; Technology; Artificial pancreas; Pancreas transplantation; Islet transplantation; Stem cells
Categories
Funding
- Universita degli Studi di Padova within the CRUI-CARE Agreement
Ask authors/readers for more resources
This article discusses innovative management approaches for type 1 diabetes, covering advancements in both technological and biological aspects, including new insulin formulations and devices, insulin pumps, continuous glucose monitoring systems, and artificial pancreas, emphasizing the importance of biological approaches for replacing insulin.
Type 1 diabetes mellitus imposes a significant burden of complications and mortality, despite important advances in treatment: subjects affected by this disease have also a worse quality of life-related to disease management. To overcome these challenges, different new approaches have been proposed, such as new insulin formulations or innovative devices. The introduction of insulin pumps allows a more physiological insulin administration with a reduction of HbA1c level and hypoglycemic risk. New continuous glucose monitoring systems with better accuracy have allowed, not only better glucose control, but also the improvement of the quality of life. Integration of these devices with control algorithms brought to the creation of the first artificial pancreas, able to independently gain metabolic control without the risk of hypo- and hyperglycemic crisis. This approach has revolutionized the management of diabetes both in terms of quality of life and glucose control. However, complete independence from exogenous insulin will be obtained only by biological approaches that foresee the replacement of functional beta cells obtained from stem cells: this will be a major challenge but the biggest hope for the subjects with type 1 diabetes. In this review, we will outline the current scenario of innovative diabetes management both from a technological and biological point of view, and we will also forecast some cutting-edge approaches to reduce the challenges that hamper the definitive cure of diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available